Cite
MLA Citation
Ali A. Rizvi et al.. “Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections.” Expert opinion on drug safety, vol. 21, no. 3, 2022, pp. 291–293. http://access.bl.uk/ark:/81055/vdc_100152625790.0x000025